WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:WntResearch AB (WNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8008
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company’s development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstituting the effect of Wnt-5a in breast cancer cells. Its Foxy-5 peptide is being tested in other situations including other types of cancer and non-cancer diseases. The company’s Box-5 peptide that is in preclinical phase for antagonising the effects of Wnt-5a. It conducts study of colon and rectal cancer patients for the determination of cancer type and patient number in the Phase 2 study. WntResearch is headquartered in Malmo, Sweden.

WntResearch AB (WNT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WntResearch AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WntResearch AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
WntResearch AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biovica Enters into Agreement with WntResearch 10
Equity Offering 11
WntResearch to Raise USD8 Million in Rights Offering of Units 11
WntResearch Raises USD2.8 Million in Rights Offering of Shares 12
WntResearch Raises USD38 Million in Rights Offering of Shares 13
WntResearch Raises USD0.3 Million in Public Offering of Shares 14
WntResearch AB – Key Competitors 15
WntResearch AB – Key Employees 16
WntResearch AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Aug 25, 2017: Henrik Lawaetz Resigns as CEO of WntResearch 18
Clinical Trials 19
Sep 25, 2017: WntResearch Provides Further Information on the Planned Phase 2 Trial with the Drug Candidate Foxy-5 19
Aug 14, 2017: Wntresearch Announces that the Last Patient has been Treated in a Phase 1b Study with the Drug Candidate Foxy-5 21
May 17, 2017: WntResearch Provides Update on the Preparations for the Start of a Phase 2 Study with the Drug Candidate Foxy-5 22
Mar 21, 2017: WntResearch announces positive results from clinical study with drug candidate Foxy-5 23
Feb 21, 2017: WntResearch Provides Update on the Clinical Development of the Drug Candidate Foxy-5 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
WntResearch AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WntResearch AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WntResearch AB, Deals By Therapy Area, 2012 to YTD 2018 8
WntResearch AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biovica Enters into Agreement with WntResearch 10
WntResearch to Raise USD8 Million in Rights Offering of Units 11
WntResearch Raises USD2.8 Million in Rights Offering of Shares 12
WntResearch Raises USD38 Million in Rights Offering of Shares 13
WntResearch Raises USD0.3 Million in Public Offering of Shares 14
WntResearch AB, Key Competitors 15
WntResearch AB, Key Employees 16
WntResearch AB, Subsidiaries 17

List of Figures
WntResearch AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WntResearch AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WntResearch AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Postnl N.V.:企業の戦略・SWOT・財務分析
    Postnl N.V. - Strategy, SWOT and Corporate Finance Report Summary Postnl N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kura Oncology Inc (KURA)-製薬・医療分野:企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • IRLAB Therapeutics AB (IRLAB A):製薬・医療:M&Aディール及び事業提携情報
    Summary IRLAB Therapeutics AB (IRL) is a pharmaceutical company that discovers and develops drugs to treat central nervous system associated diseases. The company conducts flagship technology integrative screening process, a phenotypic screening and systems pharmacology process is used for developme …
  • Avanza Bank Holding AB:企業の戦略・SWOT・財務分析
    Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report Summary Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Santen Pharmaceutical Co Ltd (4536):製薬・医療:M&Aディール及び事業提携情報
    Summary Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC …
  • Chico’s FAS Inc:戦略・SWOT・企業財務分析
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Petroleo Brasileiro S.A. (Petrobras):戦略・SWOT・企業財務分析
    Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • TRACON Pharmaceuticals Inc (TCON):製薬・医療:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • KB Home:企業の戦略・SWOT・財務分析
    KB Home - Strategy, SWOT and Corporate Finance Report Summary KB Home - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Krka, d. d., Novo mesto:戦略・SWOT・企業財務分析
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Telormedix SA-製薬・医療分野:企業M&A・提携分析
    Summary Telormedix SA (Telormedix) is a biopharmaceutical company. The company develops and provides immune drugs for the treatment of cancer and other infectious diseases. It offers products such as TMX-201, TMX-202 and vesimune (TMX-101). Its vesimune (TMX-101) provides treatment for superficial b …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Grupo SATA:企業の戦略的SWOT分析
    Grupo SATA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Duke Energy Carolinas LLC:企業の発電所・SWOT分析2018
    Duke Energy Carolinas LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務分析
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Veniti Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veniti Inc (Veniti) is a medical device company that develops venous system management solutions. The company manufactures, develops, and markets medical devices for the treatment of chronic venous diseases. It offers VICI venous stent system that is used to treat venous outflow obstruction …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆